# Mercantile Bank Corp: financial statements, quarterly

MBWM · Nasdaq · CIK 1042729 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mbwm.md) · [Financials](/companies/mbwm/financials.md) · [Filings](/companies/mbwm/filings.md) · [Insiders](/companies/mbwm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mbwm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [25.2 d](/filings/0001437749-24-006268.md) | [29.4](/filings/0001437749-24-014488.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.2 d](/filings/0001437749-26-005997.md) | [5.4](/filings/0001437749-25-014197.md) | [4.7](/filings/0001437749-25-024287.md) | [4.9](/filings/0001437749-25-032482.md) | [3.6 d](/filings/0001437749-26-005997.md) | [4.5](/filings/0001437749-26-014320.md) | [3.3](/filings/0001437749-26-025168.md) | [3.7](/filings/0001437749-26-034072.md) | [3.2 d](/filings/0001437749-26-005997.md) | [4.6](/filings/0001437749-26-014320.md) | [5.3](/filings/0001437749-26-025168.md) | [4.9](/filings/0001437749-26-034072.md) |
| Net income | $m | [20.0 d](/filings/0001437749-26-005997.md) | [21.6](/filings/0001437749-25-014197.md) | [18.8](/filings/0001437749-25-024287.md) | [19.6](/filings/0001437749-25-032482.md) | [19.6 d](/filings/0001437749-26-005997.md) | [19.5](/filings/0001437749-26-014320.md) | [22.6](/filings/0001437749-26-025168.md) | [23.8](/filings/0001437749-26-034072.md) | [22.8 d](/filings/0001437749-26-005997.md) | [22.7](/filings/0001437749-26-014320.md) | [25.9](/filings/0001437749-26-025168.md) | [24.1](/filings/0001437749-26-034072.md) |
| Diluted EPS | $ per share | not reported | [1.34](/filings/0001437749-25-014197.md) | [1.17](/filings/0001437749-25-024287.md) | [1.22](/filings/0001437749-25-032482.md) | not reported | [1.21](/filings/0001437749-26-014320.md) | [1.39](/filings/0001437749-26-025168.md) | [1.46](/filings/0001437749-26-034072.md) | not reported | [1.32](/filings/0001437749-26-014320.md) | [1.50](/filings/0001437749-26-025168.md) | [1.39](/filings/0001437749-26-034072.md) |
| Basic EPS | $ per share | not reported | [1.34](/filings/0001437749-25-014197.md) | [1.17](/filings/0001437749-25-024287.md) | [1.22](/filings/0001437749-25-032482.md) | not reported | [1.21](/filings/0001437749-26-014320.md) | [1.39](/filings/0001437749-26-025168.md) | [1.46](/filings/0001437749-26-034072.md) | not reported | [1.32](/filings/0001437749-26-014320.md) | [1.50](/filings/0001437749-26-025168.md) | [1.39](/filings/0001437749-26-034072.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [5,353](/filings/0001437749-25-005844.md) | [5,466](/filings/0001437749-24-014488.md) | [5,602](/filings/0001437749-24-024367.md) | [5,917](/filings/0001437749-24-032883.md) | [6,052](/filings/0001437749-26-005997.md) | [6,141](/filings/0001437749-25-014197.md) | [6,181](/filings/0001437749-25-024287.md) | [6,308](/filings/0001437749-25-032482.md) | [6,835](/filings/0001437749-26-034072.md) | [6,945](/filings/0001437749-26-014320.md) | [6,819](/filings/0001437749-26-025168.md) | [7,163](/filings/0001437749-26-034072.md) |
| Total liabilities | $m | [4,831](/filings/0001437749-25-005844.md) | [4,929](/filings/0001437749-24-014488.md) | [5,051](/filings/0001437749-24-024367.md) | [5,334](/filings/0001437749-24-032883.md) | [5,468](/filings/0001437749-26-005997.md) | [5,533](/filings/0001437749-25-014197.md) | [5,549](/filings/0001437749-25-024287.md) | [5,651](/filings/0001437749-25-032482.md) | [6,110](/filings/0001437749-26-034072.md) | [6,208](/filings/0001437749-26-014320.md) | [6,064](/filings/0001437749-26-025168.md) | [6,419](/filings/0001437749-26-034072.md) |
| Shareholders' equity | $m | [522](/filings/0001437749-26-005997.md) | [537](/filings/0001437749-25-024287.md) | [551](/filings/0001437749-25-032482.md) | [583](/filings/0001437749-25-032482.md) | [585](/filings/0001437749-26-034072.md) | [608](/filings/0001437749-26-025168.md) | [632](/filings/0001437749-26-034072.md) | [658](/filings/0001437749-26-034072.md) | [725](/filings/0001437749-26-034072.md) | [737](/filings/0001437749-26-025168.md) | [755](/filings/0001437749-26-034072.md) | [744](/filings/0001437749-26-034072.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(7.3) d](/filings/0001437749-26-005997.md) | [40.2](/filings/0001437749-25-014197.md) | [9.1 d](/filings/0001437749-25-024287.md) | [(8.1) d](/filings/0001437749-25-032482.md) | [59.9 d](/filings/0001437749-26-005997.md) | [(3.0)](/filings/0001437749-26-014320.md) | [(7.8) d](/filings/0001437749-26-025168.md) | [23.1 d](/filings/0001437749-26-034072.md) | [5.6 d](/filings/0001437749-26-005997.md) | [28.3](/filings/0001437749-26-014320.md) | [15.3 d](/filings/0001437749-26-025168.md) | [47.1 d](/filings/0001437749-26-034072.md) |
| Dividends paid | $m | [5.3 d](/filings/0001437749-26-005997.md) | [5.5](/filings/0001437749-25-014197.md) | [5.5 d](/filings/0001437749-25-024287.md) | [5.7 d](/filings/0001437749-25-032482.md) | [5.7 d](/filings/0001437749-26-005997.md) | [5.9](/filings/0001437749-26-014320.md) | [5.9 d](/filings/0001437749-26-025168.md) | [6.1 d](/filings/0001437749-26-034072.md) | [6.1 d](/filings/0001437749-26-005997.md) | [6.6](/filings/0001437749-26-014320.md) | [6.6 d](/filings/0001437749-26-025168.md) | [6.8 d](/filings/0001437749-26-034072.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.0](/filings/0001437749-24-014488.md) | [16.0](/filings/0001437749-24-024367.md) | [16.0](/filings/0001437749-24-032883.md) | [16.1](/filings/0001437749-25-014197.md) | [16.1](/filings/0001437749-25-024287.md) | [16.1](/filings/0001437749-25-032482.md) | [16.2](/filings/0001437749-26-014320.md) | [16.2](/filings/0001437749-26-025168.md) | [16.2](/filings/0001437749-26-034072.md) | [17.2](/filings/0001437749-26-014320.md) | [17.3](/filings/0001437749-26-025168.md) | [17.3](/filings/0001437749-26-034072.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,288,406 at 2026-10-23, from the cover of the [10-Q filed 2026-10-30](/filings/0001437749-26-034072.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 03:06 ET. No prices; not investment advice.